Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Opacifying preparations for x-ray examinations; diagnostic reageants designed to be administered to the patient
Opacifying preparations for x-ray examinations; diagnostic reagents
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
Historical data shows pricing from $19.32 to $32.20.. | |
Does NSN 6505-00-159-5008 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
Health Services Administration, Kuwait, and Republic Of Korea | |
What is the NIIN of NSN 6505-00-159-5008? | |
001595008 or 00-159-5008 | |
Does NSN 6505-00-159-5008 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6505-00-159-5008? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Sep 22, 1971 |
Ld50 lc50 mixture: none established
routes of entry: inhalation: no skin: no ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: oral: mild/transitory effects.Lg amts
of certain meglumine salts may result in nau,vomit,&/or
diarr,dehydration,electrolyte disturb,occassionally
hypersens(allergic)rx,hyperthyroidism.Inhal: not a haz.S kin/eye: no
info.Has produced hypersens or anaphylactoid rxs manifested by
edema of face/glottis,resp distress,(suppleme)
explanation of carcinogenicity: per msds: carcinogen
lists: iarc/ntp/osha: no.
effects of overexposure: nausea, vomiting, diarr, dehydration,
electrolyte disturbances, hypersensitivity rx, hyperthyroidism,
anaphylactoid rxs manifested by edema of face/glottis, resp
distress, convulsions, shock.
medical cond aggravated by exposure: sens to iodine.Personal/family
history of bronchial asthma,sign allergies,previous rxs to contrast
agents.When given in lg vol for diag procedures multiple
myeloma,pheochromocytoma,sickle cell aggravt
First aid: eye: flush w/lg amts of water for 15-20mins. Skin: wash w/soap
& water. Get med attn if irrit develops/persists. Ingest: get med
attn immed. Inhal: remove to fresh air. If difficulty in breathing
administ er oxygen. If not breathing artificial respiration can be
attempted. Get med attn immed.
Hcc: t6
boiling pt: b.P. Text: n/available
ph: 6-7.7
solubility in water: miscible
appearance and odor: colorless to pale yellow aqueous liquid, pratically
odorless
Stability indicator/materials to avoid: yes
none known
stability condition to avoid: avoid excessive heat. Protect from light.
hazardous decomposition products: thermal decomposition or burning may
produce noxious proudcts including co, co2, hi, ix (reddish-brown
gas), nox.
Waste disposal methods: dispose of in accordance w/all local, state and
federal regulations or w/regs of country in which matl is used.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: diatrizoate meglumine
fraction by wt: 66%
other rec limits: none recommended
ingred name: diatrizoate sodium
fraction by wt: 10%
other rec limits: none recommended
ingred name: water
cas: 7732-18-5
rtecs #: zc0110000
fraction by wt: >1%
other rec limits: none recommended
ingred name: edetate disodium
fraction by wt: see #7%
other rec limits: none recommended
ingred name: sodium citrate (cas# not given by msds)
fraction by wt: see #7%
other rec limits: none recommended
ingred name: sodium hydroxide (sara iii)
cas: 1310-73-2
rtecs #: wb4900000
fraction by wt: see #7%
other rec limits: none recommended
osha pel: 2 mg/m3
acgih tlv: c 2 mg/m3; 9394
epa rpt qty: 1000 lbs
dot rpt qty: 1000 lbs
ingred name: ingreds #4-6 present @
rtecs #: 9999999zz
fraction by wt:
other rec limits: none recommended
Routes of entry: inhalation: no skin: no ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: eyes: splashes may cause mechanical
irritation.
explanation of carcinogenicity: none
effects of overexposure: irritation & gi disturbances.
medical cond aggravated by exposure: allergy to iodine/iodinated
substances.
First aid: ingestion: if large amounts ingested, give water to drink.
skin: wash exposed area w/soap & water. Eyes: immediately flush
w/plenty of water for 15 mins. Obtain medical attention in all
cases.
Boiling pt: b.P. Text: 212f
melt/freeze pt: m.P/f.P text: 32f
spec gravity: 1.4-1.45
solubility in water: complete
appearance and odor: clear aqueous solution w/no odor.
Stability indicator/materials to avoid: yes
stability condition to avoid: light.
hazardous decomposition products: when heated to decomposition: toxic
fumes of nitrous oxides & iodine.
Waste disposal methods: collected spills may be flushed to sewer w/large
amounts of water. Containerized material may be disposed of in an
approved waste faciltiy. Dispose of iaw/federal, state & local
regulations. (see supp )
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: diatrizoate meglumine *96-4*
cas: 131-49-7
rtecs #: lz4315000
fraction by wt: 66%
ingred name: sodium diatrizoate
cas: 737-31-5
rtecs #: dg6125000
fraction by wt: 10%
ingred name: proprietary components
fraction by wt: 24%